ORGONasdaqPharmaceutical PreparationsFiscal year ends December 31
Organogenesis Holdings Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026
$1.02+0.02 (+2.03%)
Close on Oct 19, 2026
- Market cap
- $131.25M
- P/E (TTM)
- –
- Dividend yield
- –
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Held by institutions
53.2%
68M of 129M shares
Institutional holders
135
31 new, 15 sold out
Net institutional buying
7M
In Q2 2026
Insider trades, 12 months
2 buys · 4 sales
Net sold $2.58M
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| Soleus Capital Management, L.P. | 9,985,951 | 7.90% | 13G (passive) amendment | Dec 31, 2025 |
| Thompson Dean | 28,680,359 | 18.00% | 13D (active) | Nov 12, 2024 |
| Alan A. Ades | 22,319,836 | 17.60% | 13D (active) amendment | Jun 24, 2025 |
| Soleus Capital Group, LLC | 12,484,876 | 9.90% | 13G (passive) amendment | Dec 31, 2024 |
| Glenn H. Nussdorf | 12,248,560 | 9.70% | 13D (active) amendment | May 14, 2025 |
| Morgan Stanley | 11,505,331 | 8.70% | 13G (passive) | Dec 31, 2023 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of ORGO | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| Morgan Stanley | 11,721,609 | 9.11% | $28.48M | +104,814 | 0.00% |
| Soleus Capital Management, L.P. | 10,140,951 | 7.88% | $24.64M | +55,000 | 0.85% |
| BlackRock, Inc. | 7,249,528 | 5.63% | $17.62M | +2,349,777 | 0.00% |
| Assenagon Asset Management S.A. | 3,935,904 | 3.06% | $9.56M | +1,967,952 | 0.01% |
| Dimensional Fund Advisors LP | 3,050,297 | 2.37% | $7.41M | +159,291 | 0.00% |
| Aqr Capital Management LLC | 3,011,753 | 2.34% | $7.32M | +2,130,036 | 0.00% |
| Vanguard Capital Management LLC | 2,905,919 | 2.26% | $7.06M | +5,103 | 0.00% |
| D. E. Shaw & Co., Inc. | 2,888,313 | 2.24% | $7.02M | +590,339 | 0.00% |
| Geode Capital Management, LLC | 1,935,554 | 1.50% | $4.70M | +151,590 | 0.00% |
| Deutsche Bank AG\ | 1,706,186 | 1.33% | $4.15M | +505 | 0.00% |
| Vanguard Portfolio Management LLC | 1,607,729 | 1.25% | $3.91M | +158,637 | 0.00% |
| Acadian Asset Management LLC | 1,545,086 | 1.20% | $3.75K | −31,559 | 0.00% |
| State Street Corp | 1,519,955 | 1.18% | $3.69M | −5,153 | 0.00% |
| Renaissance Technologies LLC | 1,017,113 | 0.79% | $2.47M | −51,425 | 0.00% |
| Charles Schwab Investment Management Inc | 905,024 | 0.70% | $2.20M | +25,192 | 0.00% |
| Goldman Sachs Group Inc | 887,399 | 0.69% | $2.16M | +367,049 | 0.00% |
| Citadel Advisors LLC | 867,929 | 0.67% | $2.11M | +323,694 | 0.00% |
| Flax Pond Capital, LLC | 842,682 | 0.65% | $2.02M | +422,591 | 0.75% |
| SG Americas Securities, LLC | 772,737 | 0.60% | $1.88K | −18,029 | 0.00% |
| Jacobs Levy Equity Management, Inc | 692,197 | 0.54% | $1.68M | New | 0.01% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 135 | 68M | 53.2% | 31 / 55 | 32 / 15 | 13M | 6M |
| Q1 2026 | 121 | 62M | 48.0% | 16 / 35 | 48 / 40 | 9M | 11M |
| Q4 2025 | 147 | 69M | 54.0% | 35 / 42 | 47 / 9 | 9M | 8M |
| Q3 2025 | 121 | 69M | 53.3% | 22 / 31 | 44 / 16 | 4M | 4M |
| Q2 2025 | 115 | 69M | 54.0% | 22 / 30 | 49 / 41 | 14M | 9M |
| Q1 2025 | 136 | 65M | 50.5% | 28 / 44 | 47 / 11 | 8M | 6M |
| Q4 2024 | 120 | 63M | 48.7% | 22 / 41 | 35 / 13 | 5M | 6M |
| Q3 2024 | 112 | 64M | 49.9% | 14 / 40 | 39 / 15 | 11M | 5M |
| Q2 2024 | 116 | 63M | 49.1% | 19 / 51 | 31 / 27 | 9M | 26M |
| Q1 2024 | 124 | 80M | 62.4% | 28 / 37 | 45 / 12 | 14M | 5M |
| Q4 2023 | 108 | 72M | 55.7% | 21 / 33 | 37 / 16 | 27M | 7M |
| Q3 2023 | 104 | 53M | 40.8% | 14 / 35 | 37 / 22 | 10M | 9M |
Top mutual fund and ETF holders
Latest monthly portfolio reports (Form N-PORT)
| Fund | Shares | % of ORGO | Value | % of fund | As of |
|---|---|---|---|---|---|
| Vanguard Total Stock Market Index Fund | 1,991,446 | 1.55% | $4.84M | 0.00% | Jun 30, 2026 |
| iShares Russell 2000 ETF | 1,804,253 | 1.40% | $4.38M | 0.01% | Jun 30, 2026 |
| Vanguard Extended Market Index Fund | 842,139 | 0.65% | $2.05M | 0.00% | Jun 30, 2026 |
| Fidelity Small Cap Index Fund | 754,323 | 0.59% | $1.79M | 0.01% | Jul 31, 2026 |
| iShares Russell 2000 Value ETF | 629,191 | 0.49% | $1.53M | 0.01% | Jun 30, 2026 |
| Vanguard Explorer Fund | 492,497 | 0.38% | $1.17M | 0.01% | Jul 31, 2026 |
| Fidelity Extended Market Index Fund | 396,236 | 0.31% | $1.02M | 0.00% | May 31, 2026 |
| U.S. Targeted Value Portfolio | 356,422 | 0.28% | $844.72K | 0.01% | Jul 31, 2026 |
| Vanguard Russell 2000 Index Fund | 352,129 | 0.27% | $904.97K | 0.01% | May 31, 2026 |
| Schwab U.S. Small-Cap ETF | 350,724 | 0.27% | $901.36K | 0.00% | May 31, 2026 |
| Schwab Small-Cap Equity Fund | 341,648 | 0.27% | $809.71K | 0.12% | Jul 31, 2026 |
| Vanguard Strategic Equity Fund | 334,062 | 0.26% | $811.77K | 0.01% | Jun 30, 2026 |
| Dimensional U.S. Small Cap ETF | 295,905 | 0.23% | $701.29K | 0.00% | Jul 31, 2026 |
| U.S. Small Cap Value Portfolio | 284,690 | 0.22% | $674.72K | 0.00% | Jul 31, 2026 |
| Dimensional US Small Cap Value ETF | 267,878 | 0.21% | $634.87K | 0.01% | Jul 31, 2026 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Gary S. Gillheeney | President and CEO, Director | 4,721,298 | 3.67% | Mar 3, 2026 |
| Brian Grow | Chief Commercial Officer | 902,144 | 0.70% | Apr 24, 2026 |
| Robert Cavorsi | Vice President, Strategy | 275,524 | 0.21% | Mar 3, 2026 |
| Patrick Bilbo | Chief Operating Officer | 1,250,112 | 0.97% | Mar 3, 2026 |
| Antonio S. Montecalvo | Vice President, Health Policy | 238,498 | 0.19% | Mar 3, 2026 |
| David Francisco | Chief Financial Officer | 745,999 | 0.58% | Mar 3, 2026 |
| Lori Freedman | Chief Admin. and Legal Officer | 1,023,643 | 0.80% | Mar 3, 2026 |
| Patrick McGuire | Chief Accounting Officer | 16,965 | 0.01% | Feb 27, 2026 |
| Michael Joseph Driscoll | Director | 225,707 | 0.18% | Mar 11, 2026 |
| Arthur S. Leibowitz | Director | 291,014 | 0.23% | Mar 11, 2026 |
| Jon L. Giacomin | Director | 241,026 | 0.19% | Feb 20, 2026 |
| Gilberto Quintero | Director | 239,073 | 0.19% | Feb 20, 2026 |
| Prathyusha Duraibabu | Director | 247,047 | 0.19% | Feb 20, 2026 |
| Michele Ilene Korfin | Director | 239,073 | 0.19% | Feb 20, 2026 |
| Garrett Lustig | Director | 125,742 | 0.10% | Feb 20, 2026 |
| Glenn H. Nussdorf | Director | 11,903,172 | 9.25% | Dec 18, 2025 |
| Alan A. Ades | Director, 10% owner | 169,834,688 | 131.99% | Jan 13, 2025 |
| Erani 2012 Issue Trust dated 12/20/12 Dennis | 10% owner | 59,007,134 | 45.86% | Jan 13, 2025 |
| Investors LLC Organo | 10% owner | 118,896,054 | 92.40% | Jan 13, 2025 |
| Starr Wisdom | 10% owner | 195,109,087 | 151.63% | Jan 13, 2025 |
| GN 2016 Organo 10-Year GRAT u/a/d September 30, 2016 | 10% owner | 59,007,134 | 45.86% | Jan 13, 2025 |
| Erani Family Trust dated 12/29/2012 Albert | 10% owner | 102,170,804 | 79.40% | Jan 13, 2025 |
| Ades 2014 GRAT Alan | 10% owner | 118,896,054 | 92.40% | Jan 13, 2025 |
| Dennis Erani | 10% owner | 118,896,054 | 92.40% | Jan 13, 2025 |
| Albert Erani | 10% owner | 52,795,955 | 41.03% | Jan 13, 2025 |
| GN 2016 Family Trust u/a/d August 12, 2016 | 10% owner | 119,880,379 | 93.17% | Jan 13, 2025 |
| PFG LLC Organo | 10% owner | 68,594,976 | 53.31% | Jan 13, 2025 |
| Josette Ades | 10% owner | 102,170,804 | 79.40% | Jan 13, 2025 |
| RED Holdings, LLC | 10% owner | 59,223,027 | 46.03% | Jan 13, 2025 |
| Thompson Dean | 10% owner | 38,841,184 | 30.19% | Nov 19, 2024 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Michael Joseph Driscoll Director | Mar 9, 2026 | Buy | +10,000 | $2.67 | $26.70K | 225,707 |
| Arthur S. Leibowitz Director | Mar 9, 2026 | Buy | +5,000 | $2.68 | $13.40K | 291,014 |
| Robert Cavorsi Vice President, Strategy | Mar 1, 2026 | Tax withholding | −700 | $3.21 | $2.25K | 275,524 |
| Patrick Bilbo Chief Operating Officer | Feb 18, 2026 | Tax withholding | −16,375 | $3.84 | $62.88K | 1,128,312 |
| Patrick Bilbo Chief Operating Officer | Feb 18, 2026 | Award | +49,102 | – | – | 1,144,687 |
| David Francisco Chief Financial Officer | Feb 18, 2026 | Award | +44,040 | – | – | 745,999 |
| David Francisco Chief Financial Officer | Feb 18, 2026 | Tax withholding | −14,687 | $3.84 | $56.40K | 731,312 |
| Lori Freedman Chief Admin. and Legal Officer | Feb 18, 2026 | Tax withholding | −14,411 | $3.84 | $55.34K | 1,023,643 |
| Lori Freedman Chief Admin. and Legal Officer | Feb 18, 2026 | Award | +43,212 | – | – | 1,038,054 |
| Antonio S. Montecalvo Vice President, Health Policy | Feb 18, 2026 | Award | +11,330 | – | – | 230,016 |
| Antonio S. Montecalvo Vice President, Health Policy | Feb 18, 2026 | Tax withholding | −3,778 | $3.84 | $14.51K | 226,238 |
| Gary S. Gillheeney President and CEO, Director | Feb 18, 2026 | Award | +188,856 | – | – | 4,323,398 |
| Gary S. Gillheeney President and CEO, Director | Feb 18, 2026 | Tax withholding | −91,311 | $3.84 | $350.63K | 4,232,087 |
| Robert Cavorsi Vice President, Strategy | Feb 18, 2026 | Tax withholding | −5,487 | $3.84 | $21.07K | 276,224 |
| Robert Cavorsi Vice President, Strategy | Feb 18, 2026 | Award | +16,454 | – | – | 281,711 |
| Brian Grow Chief Commercial Officer | Feb 18, 2026 | Award | +48,818 | – | – | 911,611 |
| Brian Grow Chief Commercial Officer | Feb 18, 2026 | Tax withholding | −11,887 | $3.84 | $45.65K | 899,724 |
| Antonio S. Montecalvo Vice President, Health Policy | Feb 18, 2026 | Award | +11,218 | – | – | 229,904 |
| Antonio S. Montecalvo Vice President, Health Policy | Feb 18, 2026 | Tax withholding | −3,741 | $3.84 | $14.37K | 226,163 |
| Antonio S. Montecalvo Vice President, Health Policy | Feb 18, 2026 | Award | +40,625 | – | – | 218,686 |
| Prathyusha Duraibabu Director | Feb 18, 2026 | Award | +48,828 | – | – | 247,047 |
| Gary S. Gillheeney President and CEO, Director | Feb 18, 2026 | Award | +890,625 | – | – | 4,134,542 |
| Gary S. Gillheeney President and CEO, Director | Feb 18, 2026 | Award | +186,968 | – | – | 4,321,510 |
| Gary S. Gillheeney President and CEO, Director | Feb 18, 2026 | Tax withholding | −90,398 | $3.84 | $347.13K | 4,231,112 |
| Patrick Bilbo Chief Operating Officer | Feb 18, 2026 | Award | +210,937 | – | – | 1,095,585 |
| Patrick Bilbo Chief Operating Officer | Feb 18, 2026 | Award | +48,612 | – | – | 1,144,197 |
| Patrick Bilbo Chief Operating Officer | Feb 18, 2026 | Tax withholding | −16,212 | $3.84 | $62.25K | 1,127,985 |
| Garrett Lustig Director | Feb 18, 2026 | Award | +48,828 | – | – | 125,742 |
| Michael Joseph Driscoll Director | Feb 18, 2026 | Award | +48,828 | – | – | 215,707 |
| Jon L. Giacomin Director | Feb 18, 2026 | Award | +48,828 | – | – | 241,026 |
| Arthur S. Leibowitz Director | Feb 18, 2026 | Award | +48,828 | – | – | 286,014 |
| Gilberto Quintero Director | Feb 18, 2026 | Award | +48,828 | – | – | 239,073 |
| David Francisco Chief Financial Officer | Feb 18, 2026 | Award | +43,602 | – | – | 745,561 |
| David Francisco Chief Financial Officer | Feb 18, 2026 | Award | +195,312 | – | – | 701,959 |
| David Francisco Chief Financial Officer | Feb 18, 2026 | Tax withholding | −14,541 | $3.84 | $55.84K | 731,020 |
| Robert Cavorsi Vice President, Strategy | Feb 18, 2026 | Award | +93,750 | – | – | 265,257 |
| Robert Cavorsi Vice President, Strategy | Feb 18, 2026 | Tax withholding | −5,432 | $3.84 | $20.86K | 276,115 |
| Robert Cavorsi Vice President, Strategy | Feb 18, 2026 | Award | +16,290 | – | – | 281,547 |
| Brian Grow Chief Commercial Officer | Feb 18, 2026 | Award | +48,330 | – | – | 911,123 |
| Brian Grow Chief Commercial Officer | Feb 18, 2026 | Award | +234,375 | – | – | 862,793 |
| Brian Grow Chief Commercial Officer | Feb 18, 2026 | Tax withholding | −11,768 | $3.84 | $45.19K | 899,355 |
| Michele Ilene Korfin Director | Feb 18, 2026 | Award | +48,828 | – | – | 239,073 |
| Lori Freedman Chief Admin. and Legal Officer | Feb 18, 2026 | Award | +203,125 | – | – | 994,842 |
| Lori Freedman Chief Admin. and Legal Officer | Feb 18, 2026 | Tax withholding | −14,267 | $3.84 | $54.79K | 1,023,355 |
| Lori Freedman Chief Admin. and Legal Officer | Feb 18, 2026 | Award | +42,780 | – | – | 1,037,622 |
| Patrick Bilbo Chief Operating Officer | Feb 15, 2026 | Tax withholding | −28,331 | $3.73 | $105.67K | 915,617 |
| Patrick Bilbo Chief Operating Officer | Feb 15, 2026 | Tax withholding | −5,114 | $3.73 | $19.08K | 943,948 |
| Patrick Bilbo Chief Operating Officer | Feb 15, 2026 | Tax withholding | −15,617 | $3.73 | $58.25K | 900,000 |
| Patrick Bilbo Chief Operating Officer | Feb 15, 2026 | Tax withholding | −15,352 | $3.73 | $57.26K | 884,648 |
| Gary S. Gillheeney President and CEO, Director | Feb 15, 2026 | Tax withholding | −24,340 | $3.73 | $90.79K | 3,490,983 |
| Gary S. Gillheeney President and CEO, Director | Feb 15, 2026 | Tax withholding | −78,646 | $3.73 | $293.35K | 3,412,337 |
| Gary S. Gillheeney President and CEO, Director | Feb 15, 2026 | Tax withholding | −82,815 | $3.73 | $308.90K | 3,329,522 |
| Gary S. Gillheeney President and CEO, Director | Feb 15, 2026 | Tax withholding | −85,605 | $3.73 | $319.31K | 3,243,917 |
| Lori Freedman Chief Admin. and Legal Officer | Feb 15, 2026 | Tax withholding | −12,761 | $3.73 | $47.60K | 805,227 |
| Lori Freedman Chief Admin. and Legal Officer | Feb 15, 2026 | Tax withholding | −13,510 | $3.73 | $50.39K | 791,717 |
| Lori Freedman Chief Admin. and Legal Officer | Feb 15, 2026 | Tax withholding | −24,428 | $3.73 | $91.12K | 817,988 |
| Lori Freedman Chief Admin. and Legal Officer | Feb 15, 2026 | Tax withholding | −4,043 | $3.73 | $15.08K | 842,416 |
| Brian Grow Chief Commercial Officer | Feb 15, 2026 | Tax withholding | −11,144 | $3.73 | $41.57K | 628,418 |
| Brian Grow Chief Commercial Officer | Feb 15, 2026 | Tax withholding | −10,559 | $3.73 | $39.39K | 639,562 |
| Brian Grow Chief Commercial Officer | Feb 15, 2026 | Tax withholding | −3,346 | $3.73 | $12.48K | 669,031 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.
Planned insider sales
Notices of proposed sale filed on Form 144 before shares are sold
| Seller | Filed | Shares | Market value | Planned sale | Acquired through |
|---|---|---|---|---|---|
| Nussdorf Glenn Director, Stakeholder | Dec 16, 2025 | 200,000 | $1.02M | Dec 16, 2025 | Private Transaction |
| Nussdorf Glenn Director, Stakeholder | Nov 25, 2025 | 200,000 | $1.08M | Nov 25, 2025 | Private Transaction |
| Nussdorf Glenn Director, Stakeholder | Nov 24, 2025 | 100,000 | $534.38K | Nov 24, 2025 | Private Transaction |
| Michael Joseph Driscoll Director | Mar 17, 2025 | 25,000 | $127.00K | Mar 4, 2025 | Bonus |
| Gary S. Gillheeney Officer | Dec 6, 2024 | 380,000 | $1.36M | Dec 6, 2024 | Option Exercise |
| Erani Albert Part of a control group of shareholders | Jan 9, 2024 | 422,589 | $1.90M | Jan 9, 2024 | Original Issuance |
| RED Holdings, LLC Shareholder is part of a control group | Jan 9, 2024 | 2,000,000 | $8.98M | Jan 9, 2024 | Original issuance from debt conversion |